![M. Alexander Shaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
M. Alexander Shaw
Inga fler pågående positioner
Profil
M.
Alexander Shaw formerly worked at Prolifagen, Inc., as Chief Executive Officer and Nuventra, Inc., as Chief Operating Officer from 2009 to 2021.
Dr. Shaw received his undergraduate degree from Duke University and doctorate degree from Washington State University.
Tidigare kända positioner av M. Alexander Shaw
| Företag | Position | Slut |
|---|---|---|
Nuventra, Inc.
 Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical pharmacology consulting firm | Verksamhetschef | 2021-10-01 |
Prolifagen LLC
 Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Verkställande Direktör | - |
M. Alexander Shaws utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
5
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington State University
 Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuventra, Inc.
Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical pharmacology consulting firm | Commercial Services |
Prolifagen LLC
Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
